Abstract

Background: Parkin-mediated mitophagy eliminates dysfunctional mitochondria to reduce inflammatory responses caused by mtDAMPs. Given that reduced mitophagy is a hallmark of aging and AAA is an aging-associated disease, we sought to investigate the role of Parkin-mediated mitophagy in the development of AAAs. Methods: Groups of young (8-10 wks, n= 6/group) and aged (18-20 months, n=6/group) male Mito-QC mice either without intervention or underwent AAV.mPCSK9 D377Y infection and western diet feeding followed by Angiotensin II (AngII) or saline pump infusion for 28 days. Separately, young male Myh11-creER T2 Parkin fl/fl mice underwent tamoxifen (Parkin SMCKO) or vehicle injections (n=35-39/group), AAV.mPCSK9 D377Y infection, western diet feeding and AngII infusion. In vitro , MOVAs were treated with AngII and the USP30 inhibitor, a mitophagy enhancer, or vehicle followed by assessment of Parkin and mtROS. Results: VSMCs in aged Mito-QC mice, identified by a CD45 - CD90 - α-actin + profile, exhibit diminished mitophagy activity (p=0.017) and decreased Parkin expression (p=0.029). In young AAAs, VSMCs characterized as CD45 - CD90 - α-actin high and α-actin low also demonstrated decreased mitophagy (p=0.0017, p=0.0020), decreased Parkin(p=0.029), and a decreased trend in SDHB in Complex II (p=0.103) and NDUFB8 in Complex I (p=0.040) of the electron transport chain. Parkin SMCKO mice demonstrated increased AAA rupture (p=0.038), greater aneurysm size (p=0.044), reduced mtDNA copy numbers (p=0.026) and elevated mtROS compared to their controls. Parkin SMCKO mice demonstrated trends of diminished expression of respiratory complexes (p=0.070) and an exacerbated decrease in the maximal OCR involving both coupled and uncoupled activities of Complex I plus II (p=0.045, 0.028). In vitro experiments demonstrated treatment with the USP30 inhibitor reversed the reduction in mitophagy activity and mtROS increasement induced by AngII in MOVAS. Conclusions: In conclusion, mitophagy activity in aortic VSMCs and Parkin decreased with aging and separately, in AAAs and Parkin SMCKO mice, associated with exacerbation of AAA progression. These studies suggest stabilization of Parkin-dependent mitophagy could represent a novel AAA therapeutic target.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.